Insurance Disputes
Personal Injury
Wrongful Death
Job-Related Injuries
Social Security Disability
Product Liability
Hip Implant Defects
Mass Torts
Securities Fraud

Baycol, or cerivastatin, was voluntarily withdrawn from the U.S.
market on August 8, 2001, due to reports of severe and sometimes
fatal rhabdomyolysis. Introduced in the U.S. in 1997, Baycol is a
member of a class of drugs called "statins". Statins are prescribed
to patients to lower cholesterol levels by blocking the enzymes
involved in the production of cholesterol in the body.

Rhabdomyolysis is a severe adverse muscle reaction, usually
occurring in the calves or lower back. Common symptoms include:

-Muscle pain
-Dark Urine

Fatal rhabdomyolysis is most frequently observed in cases
involving the following circumstances:

-Elderly patients
-High dosages
-Taken in conjunction with gemfibrozil (LOPID and
generics), another cholesterol lowering drug

The FDA estimates Baycol has been prescribed to approximately
700,000 Americans since its introduction. If you or a member of
your family has experienced side effects such as the ones listed
above, please call (800) 256 9400, or submit your claim on-line
using the form below.

User Login
Review Your Case
Contact Information

Name :

Email :


Describe your case: